These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26847173)

  • 1. Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.
    Canlorbe G; Wang Z; Laas E; Bendifallah S; Castela M; Lefevre M; Chabbert-Buffet N; Daraï E; Aractingi S; Méhats C; Ballester M
    Mod Pathol; 2016 Apr; 29(4):391-401. PubMed ID: 26847173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer.
    Canlorbe G; Castela M; Bendifallah S; Wang Z; Lefevre M; Chabbert-Buffet N; Aractingi S; DaraÏ E; Méhats C; Ballester M
    Histol Histopathol; 2017 Sep; 32(9):941-950. PubMed ID: 28000202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
    Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray.
    Bidus MA; Risinger JI; Chandramouli GV; Dainty LA; Litzi TJ; Berchuck A; Barrett JC; Maxwell GL
    Clin Cancer Res; 2006 Jan; 12(1):83-8. PubMed ID: 16397028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.
    Backes FJ; Walker CJ; Goodfellow PJ; Hade EM; Agarwal G; Mutch D; Cohn DE; Suarez AA
    Gynecol Oncol; 2016 May; 141(2):312-317. PubMed ID: 26957478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer.
    de Foucher T; Sbeih M; Uzan J; Bendifallah S; Lefevre M; Chabbert-Buffet N; Aractingi S; Uzan C; Abd Alsalam I; Mitri R; Fontaine RH; Daraï E; Haddad B; Méhats C; Ballester M; Canlorbe G; Touboul C
    J Transl Med; 2018 May; 16(1):131. PubMed ID: 29783999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented (MELF) Pattern by Cytokeratin Immunostaining.
    Rabe KM; Klein ME; Ghatak S; Stout I; Schefter A; Erickson BK; Khalifa MA
    Am J Clin Pathol; 2021 Oct; 156(5):846-852. PubMed ID: 34125164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
    Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.
    Cusimano MC; Vicus D; Pulman K; Maganti M; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Hogen LF; Covens AL; Gien LT; Kupets R; Rouzbahman M; Clarke BA; Mirkovic J; Cesari M; Turashvili G; Zia A; Ene GEV; Ferguson SE
    JAMA Surg; 2021 Feb; 156(2):157-164. PubMed ID: 33175109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
    Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
    Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
    Kim CH; Khoury-Collado F; Barber EL; Soslow RA; Makker V; Leitao MM; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2013 Dec; 131(3):714-9. PubMed ID: 24099838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer.
    Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2020 May; 157(2):329-334. PubMed ID: 32094021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.
    Kang S; Thompson Z; McClung EC; Abdallah R; Lee JK; Gonzalez-Bosquet J; Wenham RM; Chon HS
    Int J Gynecol Cancer; 2018 Feb; 28(2):260-266. PubMed ID: 29194195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma.
    Sato K; Miyamoto M; Takano M; Tsuda H
    Virchows Arch; 2021 Nov; 479(5):883-891. PubMed ID: 34331128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 is associated with high tumor grade, myometrial invasion and lymph node invasion in endometrial endometrioid carcinoma.
    Tosun Yıldırım H; Nergiz D; Sadullahoğlu C; Süren D; Yıldırım Ş; Üreyen I; Sezer C
    Ginekol Pol; 2021; 92(8):544-549. PubMed ID: 33844251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
    de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
    PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.